Site Map
|
Contact OSI
Search
Site Map
Who We Are
Products & Pipeline
Science and Research
Investors
Media Center
Careers
Who We Are
Strategy
Corporate Governance
Bylaws of OSI Pharmaceuticals, Inc.
Audit Committee Charter
Compensation Committee Charter
Corporate Governance and Nominating Committee Charter
Investment Committee Charter
Code of Conduct
Comprehensive Compliance Program
PhRMA Code
Board & Management Team
Collaborations Opportunities
In the Community
Products & Pipeline
Oncology
Tarceva
®
(erlotinib) tablets
OSI-906 (IGF-1R)
OSI-027
(TORC1 and TORC2)
OSI-930 (VEGFR-2)
Clinical Trials
Medical Information
Novantrone
®
Patient Education
Diabetes & Obesity
Science and Research
Oncology
Discovery and Development
EMT
Translational Research Program
Research Reagents Program
Diabetes & Obesity
Core Technologies
Grants, Sponsorship & Donation Requests
Investors
Press Releases
Events & Presentations
Financial Information
Stock Information
Contact Us
Media Center
Careers
Our Culture
Community Events
Working at OSI
Equal Opportunity Employer
UK Job Opportunities
US Job Opportunities
Benefits
University Relations
